Loading...
XASE
DSS
Market cap8mUSD
Jul 03, Last price  
0.89USD
1D
0.01%
1Q
-1.69%
Jan 2017
-99.78%
Name

Dss Inc

Chart & Performance

D1W1MN
P/E
P/S
0.42
EPS
Div Yield, %
Shrs. gr., 5y
65.45%
Rev. gr., 5y
-0.32%
Revenues
19m
-36.89%
1,749,8644,834,4245,991,1966,643,0079,911,69113,381,58113,383,60417,115,00017,453,00018,287,00017,505,00019,177,00018,662,00018,515,08219,409,23017,411,00020,275,00047,307,00030,258,00019,097,000
Net income
-47m
L-41.82%
-2,842,790-4,832,366-6,986,830-8,285,142-3,990,013-4,603,890-3,222,146-4,281,0002,594,000-41,157,000-14,309,000-950,000-578,0001,464,969-2,889,1473,086,000-34,050,000-69,662,000-80,606,000-46,896,000
CFO
-9m
L-52.68%
-1,689,721-1,411,677-3,219,322-2,390,771-1,595,101-1,759,253-2,124,505-3,163,283-3,149,239-2,390,238-976,6305,466,525-1,367,530-1,382,921-5,342,874-6,152,000-8,805,000-26,953,000-19,194,000-9,082,000
Earnings
Aug 11, 2025

Profile

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged in—nonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
IPO date
Oct 27, 1993
Employees
119
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
19,097
-36.89%
30,258
-36.04%
47,307
133.33%
Cost of revenue
34,187
44,104
86,946
Unusual Expense (Income)
NOPBT
(15,090)
(13,846)
(39,639)
NOPBT Margin
Operating Taxes
8
4
172
Tax Rate
NOPAT
(15,098)
(13,850)
(39,811)
Net income
(46,896)
-41.82%
(80,606)
15.71%
(69,662)
104.59%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,189
1,519
BB yield
-50.10%
-0.41%
Debt
Debt current
1,854
48,462
47,957
Long-term debt
13,228
21,971
26,617
Deferred revenue
Other long-term liabilities
14,875
507
Net debt
3,151
52,429
26,281
Cash flow
Cash from operating activities
(9,082)
(19,194)
(26,953)
CAPEX
(133)
(818)
(2,802)
Cash from investing activities
8,811
8,936
(17,969)
Cash from financing activities
5,087
(2,417)
7,617
FCF
47,563
(8,746)
(98,923)
Balance
Cash
11,431
6,615
19,290
Long term investments
500
11,389
29,003
Excess cash
10,976
16,491
45,928
Stockholders' equity
(290,434)
(236,750)
(160,445)
Invested Capital
333,713
382,793
382,481
ROIC
ROCE
EV
Common stock shares outstanding
7,072
6,996
111,622
Price
0.90
-62.53%
2.40
-26.77%
3.28
-75.60%
Market cap
6,365
-62.12%
16,805
-95.41%
366,121
957.38%
EV
21,993
88,520
423,521
EBITDA
(12,851)
(8,640)
(26,714)
EV/EBITDA
Interest
283
553
2,910
Interest/NOPBT